Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-10.85 Mil
% of Total Estimate Gain
-10.86%

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC's Sarepta Therapeutics Inc Holding Summary

As of 2025-03-31, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC held - shares of Sarepta Therapeutics Inc(SRPT), totaling N/A. This investment constitutes 0% of their stock portfolio, and SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC now holds 0% of the outstanding Sarepta Therapeutics Inc(SRPT) stock.

The initial trade took place in 2018Q2. And since then SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC has made 8 purchases of SRPT, at an average price of $123.42, for a total of 810,072.00 shares. In addition, there have been 5 sales at an average price of $110.02 for 810,072.00 shares. Based on historical transaction data and SRPT's current price of $12.88, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC's estimated gain on his SRPT holdings is $-10.85 Mil, reflecting a -10.86% gain to date.

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC SRPT ($12.88) Holding Chart

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC SRPT ($12.88) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1